Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B.
about
Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in ChinaConcurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease.Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population.Salvianolate reduces glucose metabolism disorders in dimethylnitrosamine-induced cirrhotic rats.
P2860
Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B.
@en
Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B.
@nl
type
label
Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B.
@en
Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B.
@nl
prefLabel
Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B.
@en
Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B.
@nl
P2093
P2860
P356
P1476
Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B
@en
P2093
A M-L Chim
A W-H Chan
G L-H Wong
H L-Y Chan
V W-S Wong
P2860
P304
P356
10.1111/APT.12874
P407
P577
2014-07-13T00:00:00Z